Department of Medicine
-
November 11, 2021
VUMC team puts tool to reduce heart failure admissions to test
Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure. -
November 11, 2021
New way to bEET insulin resistance
Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered. -
November 11, 2021
International gathering scrutinizes immune response, beta cell biology in Type 1 diabetes
-
November 4, 2021
Harrison Society researcher discovers key regulator of kidney cell structure
New research from Vanderbilt could aid efforts to promote kidney regeneration after injury or to develop engineered organs. -
November 2, 2021
Shifts in neuroendocrine cancer clinical trial design
Clinical trials that focus on specific types of neuroendocrine neoplasms — heterogeneous tumors that can occur anywhere in the body — will be more likely to enhance drug development for these tumors, Vanderbilt physicians assert. -
November 1, 2021
Breast cancer survivors: eat nuts
Breast cancer survivors who reported eating nuts regularly had 50% reduced risk of breast cancer recurrence, metastasis or mortality, Vanderbilt epidemiologists found in Shanghai Breast Cancer Survival Study. -
October 28, 2021
Pancreatic beta-cell booster
Blocking inflammatory signaling improves beta-cell characteristics in a mouse model of type 2 diabetes and may provide added benefits to GLP-1R diabetes medications.